What is Tekla Healthcare Opportunities Fund Financial Strength?
Tekla Healthcare Opportunities Fund has the Financial Strength Rank of 4.
Warning Sign:
Tekla Healthcare Opportunities Fund displays poor financial strength. Usually, this is caused by too much debt for the company.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:
1. The debt burden that the company has as measured by its
Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3.
Altman Z-Score.
GuruFocus does not calculate Tekla Healthcare Opportunities Fund's interest coverage with the available data.
Tekla Healthcare Opportunities Fund's debt to revenue ratio for the quarter that ended in Sep. 2023 was -14.36.
Altman Z-Score does not apply to banks and insurance companies.
Tekla Healthcare Opportunities Fund Financial Strength Calculation
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Tekla Healthcare Opportunities Fund's Interest Expense for the
months ended in Sep. 2023 was $-7.24 Mil. Its Operating Income for the
months ended in Sep. 2023 was $0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $225.00 Mil.
Tekla Healthcare Opportunities Fund's Interest Coverage for the quarter that ended in Sep. 2023 is
The higher the ratio, the stronger the company's financial strength is.
2. Debt to revenue ratio. The lower, the better.
Tekla Healthcare Opportunities Fund's Debt to Revenue Ratio for the quarter that ended in Sep. 2023 is
3. Altman Z-Score.
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
Altman Z-Score does not apply to banks and insurance companies.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tekla Healthcare Opportunities Fund (Tekla Healthcare Opportunities Fund) Business Description
Traded in Other Exchanges
N/A
Address
1900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
Tekla Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies in the healthcare industry (including equity securities, debt securities, and pooled investment vehicles). The fund invests in securities of public and private companies.
Executives
| Bill Maher |
director |
600 WEST BROADWAY, 30TH FL., SAN DIEGO CA 92101 |
| Aberdeen Standard Investments Inc. |
other: Adviser |
1900 MARKET ST., 2ND FLOOR, PHILADELPHIA PA 19103 |
| Rose Dimartino |
director |
C/O ABRDN, 1900 MARKET STREET, PHILADELPHIA PA 19103 |
| Jaclyn Marie Matsick |
other: Director of Adviser |
C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103 |
| Marika Tooze |
other: Director of Adviser |
C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103 |
| Todd Reit |
director |
C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103 |
| James Joseph O'connor |
other: Director of Adviser |
C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103 |
| Lucia Sitar |
officer: VP and Chief Legal Officer |
1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
| Christian Pittard |
officer: President |
ONE BOW CHURCHYARD, LONDON X0 EC4M 9HH |
| Megan Kennedy |
officer: Secretary and Vice President |
1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
| Jennifer A Nichols |
other: Director of Adviser |
1735 MARKET STREET, 37TH FLOOR, PHILADELPHIA PA 19103 |
| Stephen Bird |
director |
388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10022 |
| Joseph Andolina |
officer: Chief Compliance Officer & VP |
1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
| Alan R Goodson |
officer: Vice President |
1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
| Sharon Ferrari |
officer: Treasurer and CFO |
1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
THQ has been successfully added to your